MITOLINE Trademark

Trademark Overview

On Wednesday, February 22, 2023, a trademark application was filed for MITOLINE with the United States Patent and Trademark Office. The USPTO has given the MITOLINE trademark a serial number of 97805456. The federal status of this trademark filing is PETITION TO REVIVE - RECEIVED as of Sunday, July 20, 2025. This trademark is owned by MitoCareX Bio Ltd.. The MITOLINE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development of technology in the field of amino acid sequence editing
mitoline

General Information

Serial Number97805456
Word MarkMITOLINE
Filing DateWednesday, February 22, 2023
Status612 - PETITION TO REVIVE - RECEIVED
Status DateSunday, July 20, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 2, 2024

Trademark Statements

Pseudo MarkMITO LINE
Goods and ServicesResearch and development of technology in the field of amino acid sequence editing

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, March 12, 2023
Primary Code042
First Use Anywhere DateMonday, May 1, 2023
First Use In Commerce DateMonday, May 1, 2023

Trademark Owner History

Party NameMitoCareX Bio Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNess Ziona 7403626
IL
Party NameMitoCareX Bio Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNess Ziona 7403626
IL

Trademark Events

Event DateEvent Description
Saturday, February 25, 2023NEW APPLICATION ENTERED
Sunday, March 12, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 21, 2023ASSIGNED TO EXAMINER
Tuesday, January 2, 2024PUBLISHED FOR OPPOSITION
Wednesday, November 29, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 13, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 27, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 2, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 27, 2024TEAS STATEMENT OF USE RECEIVED
Tuesday, August 27, 2024USE AMENDMENT FILED
Tuesday, October 29, 2024STATEMENT OF USE PROCESSING COMPLETE
Tuesday, October 29, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, March 12, 2025APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Thursday, June 26, 2025ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Sunday, July 20, 2025TEAS PETITION TO REVIVE RECEIVED
Thursday, June 26, 2025ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, December 12, 2024NON-FINAL ACTION E-MAILED
Thursday, December 12, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, December 12, 2024SU - NON-FINAL ACTION - WRITTEN
Wednesday, March 12, 2025APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

Related Keywords

mitoline acid sequence editing amino field development technology research